Wall Street Zen Upgrades Addus HomeCare (NASDAQ:ADUS) to “Strong-Buy”

Addus HomeCare (NASDAQ:ADUS) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

Several other research firms have also recently issued reports on ADUS. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Barclays upped their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research report on Tuesday, November 4th. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday, January 7th. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target for the company. Finally, Cowen restated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $136.90.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $107.50 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a 50 day simple moving average of $112.52 and a 200 day simple moving average of $113.25. Addus HomeCare has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The firm has a market cap of $1.99 billion, a P/E ratio of 23.02, a P/E/G ratio of 1.32 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.53 by $0.03. The firm had revenue of $362.30 million for the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The business’s revenue for the quarter was up 25.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.30 EPS. Sell-side analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the completion of the sale, the executive vice president owned 44,144 shares of the company’s stock, valued at approximately $4,811,696. This represents a 31.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold a total of 20,316 shares of company stock worth $2,215,998 in the last ninety days. 4.50% of the stock is currently owned by insiders.

Institutional Trading of Addus HomeCare

A number of large investors have recently made changes to their positions in ADUS. Larson Financial Group LLC raised its holdings in shares of Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares in the last quarter. AlphaQuest LLC bought a new position in shares of Addus HomeCare in the third quarter worth approximately $37,000. Wexford Capital LP purchased a new stake in Addus HomeCare in the third quarter valued at approximately $41,000. State of Wyoming bought a new stake in Addus HomeCare during the second quarter valued at approximately $47,000. Finally, Raymond James Financial Inc. bought a new stake in Addus HomeCare during the second quarter valued at approximately $61,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.